Press release
Generic Injectables Market Size to Reach US$ 70.4 Billion by 2028, at a Growth Rate of (CAGR) 8.3%
Generic Injectables Market Report 2023
Report Highlights
How big is the generic injectables market?
• Market Size in 2022: US$ 43.9 Billion
• Market Forecast in 2028: US$ 70.4 Billion
• Growth rate (2023 to 2028): CAGR of 8.3%
• Base Year of the Analysis: 2022
• Forecast Period: 2023-2028
What are generic injectables?
Generic injectables are pharmaceutical products that are identical or bioequivalent to the original branded injectable products but are marketed under a different brand name after the patent for the original product expires. They are manufactured using the same active pharmaceutical ingredients as the original product and are typically sold at a lower price than the branded product. They are widely used to treat various medical conditions such as cancer, infectious diseases, and autoimmune disorders. They are used in hospitals, clinics, and other medical facilities and are administered through intravenous, intramuscular, or subcutaneous routes.
Request for a free sample copy of this report: https://www.imarcgroup.com/generic-injectables-market/requestsample
What are the growth prospects and trends in the generic injectables industry?
The global market is majorly driven by the increasing demand for affordable healthcare products and services. In line with this, the expiration of patents for many branded injectable products is significantly contributing to the market. Furthermore, the growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disease is positively influencing the market. Apart from this, the expansion of the global pharmaceutical industry is creating a positive outlook for the market. Moreover, the escalating generic drug utilization and rapid technological advancements in manufacturing processes are catalyzing the market. Besides, the increasing demand for biosimilars is offering numerous opportunities for the market. Additionally, the trend toward personalized medicine is accelerating the development of new injectable treatments that can be customized to individual patient needs.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/generic-injectables-market
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Therapeutic Area:
• Oncology
• Anaesthesia
• Anti-infectives
• Parenteral Nutrition
• Cardiovascular
Breakup by Container:
• Vials
• Ampoules
• Premix
• Prefilled Syringes
Breakup by Distribution Channel:
• Hospitals
• Retail Pharmacy
Regional Insights:
• Europe
• North America
• Asia
• South America
• Others
Who are the key players operating in the industry?
The report covers the major market players including:
• Hospira (Pfizer)
• Fresenius Kabi
• Hikma
• Sandoz (Novartis)
• Sagent
• Sanofi
• Baxter
Also, Read the Top Players in the Generic Injectables Companies: https://www.imarcgroup.com/generic-injectables-companies
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
Other Reports of IMARC Group:
• https://techvizaca.com/2023/05/02/wi-fi-analytics-market-outlook-industry-growth-report-2022-2027/
• https://techvizaca.com/2023/05/02/analgesics-market-growth-analysis-industry-share-size-report-2023-2028/
• https://techvizaca.com/2023/05/02/automotive-glass-market-demand-trends-analysis-outlook-industry-report-2023-2028/
• https://techvizaca.com/2023/05/02/beauty-and-personal-care-products-market-trends-growth-overview-report-2023-2028/
• https://techvizaca.com/2023/05/02/camping-tent-market-outlook-industry-share-size-report-2022-2027/
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generic Injectables Market Size to Reach US$ 70.4 Billion by 2028, at a Growth Rate of (CAGR) 8.3% here
News-ID: 3040509 • Views: …
More Releases from IMARC Group
Automotive Control Cables Manufacturing Plant Setup Report 2025: Machinery, Raw …
Automotive control cables are essential components used to transmit mechanical force in vehicles, enabling the smooth operation of various systems such as brakes, clutches, accelerators, gear shifts, and seating mechanisms. These cables are designed for durability, flexibility, and high performance under diverse driving conditions. Their demand is directly linked to the growth of the automotive industry, aftermarket sales, and increasing consumer preference for enhanced driving comfort and safety.
Setting up an…
Halal Cosmetics Market Size, Trends, Key Players, Opportunity and Forecast 2025- …
IMARC Group, a leading market research company, has recently released a report titled "Halal Cosmetics Market Size, Share, Trends and Forecast by Type, Distribution Channel, and Region, 2025-2033." The study provides a detailed analysis of the industry, including the global halal cosmetics market size, trends, share and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Halal Cosmetics Market Highlights:
• Halal Cosmetics Market…
Comprehensive Castor Oil Processing Plant Project Report 2025: Setup Guide, Econ …
Castor oil is a versatile vegetable oil extracted from the seeds of the Ricinus communis plant. It is widely used in pharmaceuticals, cosmetics, food processing, lubricants, paints, coatings, and biodiesel production owing to its unique chemical properties, including high ricinoleic acid content. Castor oil derivatives also serve as key raw materials in the polymer, chemical, and industrial sectors.
Establishing a castor oil processing plant involves steps such as seed cleaning, dehulling,…
Honey Processing Plant Report 2025: Capital Investment, Operating Expenses and M …
Honey is a natural sweetener produced by honeybees and is valued for its nutritional, medicinal, and industrial applications. It contains antioxidants, enzymes, vitamins, and minerals that make it a popular ingredient in food and beverages, pharmaceuticals, cosmetics, and personal care products. Processed honey is widely consumed as a sweetener, used in bakery and confectionery items, beverages, dietary supplements, and skincare formulations.
Setting up a honey processing plant involves operations such as…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…
